| mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
| mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
8e-06 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
| mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
1e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.23 |
3e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
9e-05 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.2 |
0.0001 |